Hopefully A Good Re-Start from Bayer Healthcare in Mending Their Ways & Building Trust with the Prostate Cancer Community
I want to share that I am hopeful that we have made progress with Bayer Healthcare and the issues I have written about surrounding the newly approved treatment for men with castrate resistant prostate cancer, [...]
Ra 223 Dichloride (Xofigo®) Approved by the FDA
More great news for men with advanced prostate cancer that is castrate resistant and who also have symptomatic bone metastases and no known visceral metastatic disease. Today, Bayer HealthCare announced that the U.S. Food and [...]
ADJUVANT AND SALVAGE RADIOTHERAPY AFTER PROSTATECTOMY: NEW ASTRO/AUA GUIDELINE
A joint task force composed of members from the American Urological Association (AUA) and the American Society for Radiation Oncology (ASTRO) has presented formal guidelines for the use of adjuvant and salvage radiation after a [...]
The AUA Issues Specific Guidelines for the Treatment of Men with Castrate Resistant Prostate Cancer
There was a lot of interesting and important presentations at the recent American Urological Association meeting, however the one item that will have the most impact on men with advanced prostate cancer is the new [...]
That Dirty Word Sequester & Its Terrible Effect on Cancer Research & Treatment
That dirty word, sequester is making it mark, especially medical and cancer research. Hospitals and researchers are feeling the pain directly and hard. The National Institutes of Health (NIH), for example, is cutting an estimated [...]
Statin Use And Better Prostate Cancer Outcomes
Not approved, not even tested with an appropriate clinical trial, but research has again shown that the use of statins in men with prostate cancer may have a lower risk of dying from the cancer [...]